Filing Details
- Accession Number:
- 0001493152-21-032696
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-12-29 16:30:29
- Reporting Period:
- 2021-11-23
- Accepted Time:
- 2021-12-29 16:30:29
- Original Submission Date:
- 2021-11-24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1349929 | Vyant Bio Inc. | VYNT | Services-Medical Laboratories (8071) | 043462475 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1850633 | D.c. Andrew Lafrence | C/O Vyant Bio, Inc. 2 Executive Campus 2370 State Route 70, Suite 310 Cherry Hill, NJ 08002 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2021-11-23 | 5,000 | $2.00 | 34,292 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.0001 Par Value | 29,825 | Indirect | By Trust |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.9995 to $2.00 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- Includes 3,000 shares previously held directly by the Reporting Person which were transferred to this joint trust account.
Billionaire Hedge Funds
